معرفی
Professor David Killick is a European and RCVS-recognized specialist in Veterinary Oncology at the University of Liverpool's Faculty of Health and Life Sciences. He leads clinical oncology services with expertise in canine oral malignant melanoma, feline vaccine-associated sarcoma, and histiocytic diseases across companion animals.
His educational journey includes:
- Veterinary degree from the Royal Veterinary College (RVC)
- Residency in veterinary oncology at the University of Liverpool (2007-2010)
- PhD from RVC (2014) on anti-cancer immunotherapy targets
- RCVS certificate in small animal medicine (2008)
- European College of Veterinary Internal Medicine diploma (2011)
Killick's research bridges veterinary oncology with health informatics, focusing on pharmacovigilance systems and real-world data from electronic health records. His work develops machine learning tools for adverse drug reaction monitoring and expands pet cancer registries through SAVSNET collaborations. Clinical interests center on translational cancer therapies for dogs and cats.
Recent publications demonstrate a cohesive trend in applying informatics to veterinary pharmacovigilance, with strong emphasis on melanoma/lymphoma subtyping and medication error analysis. His interdisciplinary approach integrates clinical oncology, molecular diagnostics, and big data analytics to improve cancer treatment protocols.
Key honors include:
- Fellow of the Royal College of Veterinary Surgeons (2020)
- EBVS European Veterinary Specialist in Oncology (2011)
- Royal College of Veterinary Surgeons specialist certification (2013)
He supervises postgraduate trainees in oncology rotations and contributes to the Certificate of Advanced Veterinary Practice program. Major grants include £200,000 from PET PLAN CHARITABLE TRUST (2023-2025) for expanding the pet cancer registry using machine learning, and DEFRA funding (2019-2022) for adverse drug reaction reporting systems. Killick chairs ethics committees for veterinary research while leading oncology curriculum development nationally.
As Chair of the European College of Veterinary Internal Medicine Oncology group, he shapes specialty standards while directing the Faculty of Health and Life Sciences Research Ethics Committee for Veterinary Science.
